All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Not reported | 2007-006260-29 | "Estudio farmacodinámico Fase "0" de Micofenolato Mofetil (MMF, CellCept) en pacientes con cáncer de pancreas" | 2011-02-10 | due-trials |
Completed, but no date | 2008-004492-21 | Estudio biológico del efecto de GW572016 (Lapatinib) en la apoptosis celular en el Carcinoma Ductal in Situ en pacientes con cáncer de mama HER2 positivo | bad-data | |
Completed, but no date | 2009-011405-16 | BEVACIZUMAB Y TRASTUZUMAB PREOPERATORIO JUNTO CON PACLITAXEL SEMANAL SEGUIDO, TRAS CIRUGÍA, DE DOXORUBICINA LIPOSOMAL ENCAPSULADA, CICLOFOSFAMIDA Y TRASTUZUMAB EN MUJERES CON CÁNCER DE MAMA HER2 + | bad-data | |
Ongoing | 2010-019075-30 | Determinación de la respuesta del estroma a nab-paclitaxel en combinación con gemcitabina en cáncer de páncreas. Assessment of tumor stroma response to nab-placlitaxel (Abraxane) in combination with ... | not-yet-due | |
Not reported Terminated | 2010-021118-47 | Estudio fase II, abierto, multicéntrico, no aleatorizado para evaluar la eficacia y la seguridad de la combinación de lapatinib, oxaliplatino y capecitabina como tratamiento neoadyuvante en pacientes ... | 2011-12-13 | due-trials |
Ongoing | 2013-005087-25 | Gemcitabine plus nab-paclitaxel versus folfirinox as neoadjuvant treatment in patients with potentially resectable pancreatic carcinoma. NeoPAN Study Tratamiento Neoadyuvante con gemcitabina mas na... | not-yet-due |